These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 8553769)
1. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens]. Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769 [No Abstract] [Full Text] [Related]
2. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV. DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680 [TBL] [Abstract][Full Text] [Related]
3. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation]. Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549 [TBL] [Abstract][Full Text] [Related]
4. Protecting against plague: towards a next-generation vaccine. Williamson ED; Oyston PC Clin Exp Immunol; 2013 Apr; 172(1):1-8. PubMed ID: 23480179 [TBL] [Abstract][Full Text] [Related]
5. Multiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plague. Sanapala S; Rahav H; Patel H; Sun W; Curtiss R Vaccine; 2016 May; 34(21):2410-2416. PubMed ID: 27060051 [TBL] [Abstract][Full Text] [Related]
6. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Eyles JE; Butcher WA; Titball RW; Hill J Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388 [TBL] [Abstract][Full Text] [Related]
7. Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. Chiuchiolo MJ; Boyer JL; Krause A; Senina S; Hackett NR; Crystal RG J Infect Dis; 2006 Nov; 194(9):1249-57. PubMed ID: 17041851 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis. Gupta G; Khan AA; Rao DN Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784 [TBL] [Abstract][Full Text] [Related]
9. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague. Zvi A; Rotem S; Zauberman A; Elia U; Aftalion M; Bar-Haim E; Mamroud E; Cohen O Vaccine; 2017 Oct; 35(44):5995-6006. PubMed ID: 28606812 [TBL] [Abstract][Full Text] [Related]
10. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine. Demeure CE; Derbise A; Guillas C; Gerke C; Cauchemez S; Carniel E; Pizarro-Cerdá J Vaccine; 2019 Jan; 37(1):123-129. PubMed ID: 30467064 [TBL] [Abstract][Full Text] [Related]
11. [The role of T-suppressors in the formation of plague immunity in mice]. Nazarova LS; Isupov IV; Surikov NN; Piontkovskiĭ SA; Devdariani ZL; Golubeva II; Taranenko TM; Alenkina TV Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):89-93. PubMed ID: 2143614 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study by immunoblotting of the serological response in white mice and guinea pigs inoculated against plague]. Nekliaev VN; Gamleshko KhP; Rozhkov KK Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):75-6. PubMed ID: 8553775 [No Abstract] [Full Text] [Related]
13. Live-attenuated Yersinia pestis vaccines. Wang X; Zhang X; Zhou D; Yang R Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796 [TBL] [Abstract][Full Text] [Related]